Motaghedi R, Lipman EG, Hogg JE, Christos PJ, Vogiatzi MG, Angulo MA
Novo Nordisk CEO Lars Fruergaard Jrgensen said this March that the gap between demand for weight loss drugs and the supply is significant enough to take years to close
Some said the intake was smooth and that their first shipment arrived quickly, and a few even claimed the process was easier than expected
Otherwise, you may be left with disappointment
doi: 10.3389/fphar.2023.1303844 Received 28 September 2023 Accepted 30 November 2023 Published 11 December 2023 Volume 14 - 2023 Edited by Alessio Squassina, University of Cagliari, Italy Reviewed by Michele Mazzanti, University of Milan, Italy Yashmin Choudhury, Assam University, India Updates Copyright 2023 Greco, Coperchini, Croce, Magri, Teliti and Rotondi